Jennison Associates’s Oak Street Health, Inc. OSH Stock Holding History

Jennison Associates’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-339,428	Closed	-$7.3M	–	642
2022 Q4	$7.3M	Sell	339,428 -6,632	-2%	-$139K	0.01%	410
2022 Q3	$8.48M	Buy	+346,060	New	+$9.15M	0.01%	408

Other funds holding OSH

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Jennison Associates's OSH Position: Q1 2023 in Review

Jennison Associates sold out of Oak Street Health, Inc. (OSH) in Q1 2023, closing a stake of 339,428 shares — an estimated $7.3M sold.

Jennison Associates first reported a position in OSH in Q3 2022 and held it in 2 quarters. The position peaked at $8.48M in Q3 2022. 272 funds tracked by Wall St. Rank hold OSH as of Q1 2023.

Jennison Associates reported no remaining Oak Street Health, Inc. position as of Q1 2023 after selling out during the quarter.
Jennison Associates sold 339,428 Oak Street Health, Inc. shares in Q1 2023, an estimated $7.3M.
Jennison Associates first reported a position in Oak Street Health, Inc. in Q3 2022 and held it in 2 quarters.
Jennison Associates's Oak Street Health, Inc. position peaked at $8.48M in Q3 2022.
272 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q1 2023.

Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.